Bivalent Covid-19 Vaccines. Reply.
Publication
, Journal Article
Offit, PA
Published in: N Engl J Med
March 23, 2023
Duke Scholars
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
March 23, 2023
Volume
388
Issue
12
Start / End Page
1151 / 1152
Location
United States
Related Subject Headings
- Humans
- General & Internal Medicine
- COVID-19 Vaccines
- COVID-19
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Offit, P. A. (2023). Bivalent Covid-19 Vaccines. Reply. N Engl J Med, 388(12), 1151–1152. https://doi.org/10.1056/NEJMc2301323
Offit, Paul A. “Bivalent Covid-19 Vaccines. Reply.” N Engl J Med 388, no. 12 (March 23, 2023): 1151–52. https://doi.org/10.1056/NEJMc2301323.
Offit PA. Bivalent Covid-19 Vaccines. Reply. N Engl J Med. 2023 Mar 23;388(12):1151–2.
Offit, Paul A. “Bivalent Covid-19 Vaccines. Reply.” N Engl J Med, vol. 388, no. 12, Mar. 2023, pp. 1151–52. Pubmed, doi:10.1056/NEJMc2301323.
Offit PA. Bivalent Covid-19 Vaccines. Reply. N Engl J Med. 2023 Mar 23;388(12):1151–1152.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
March 23, 2023
Volume
388
Issue
12
Start / End Page
1151 / 1152
Location
United States
Related Subject Headings
- Humans
- General & Internal Medicine
- COVID-19 Vaccines
- COVID-19
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences